Welcome to kongre.net
Speaker
Vice President - Translational Biology, NRG Therapeutics
Sarah Almond, Vice President - Translational Biology at NRG Therapeutics, is speaking at Novel CNS Biomarkers Summit Europe (London, United Kingdom, 30 Nov – 2 Dec 2026) in the session “Translating Multimodal Biomarker Strategies from Preclinical Models to Early Clinical Development in ALS”.
30 Nov – 2 Dec 2026London, United Kingdom
President & Chief Executive Officer, Progenra Inc
Neurological Disorders & Biofluid Specialist, Lundbeck
Founder & Chief Executive Officer, AltPep
Co-Founder & Chief Scientific Officer, Monument Therapeutics
Senior Scientist, Biosample Project Leader, Roche
Global Program Head Neurology, Duke University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Sarah Almond, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].